Bp Plc increased its holdings in shares of CME Group Inc (NASDAQ:CME) by 4.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 106,506 shares of the financial services provider’s stock after buying an additional 4,306 shares during the quarter. CME Group accounts for about 0.8% of Bp Plc’s portfolio, making the stock its 26th largest position. Bp Plc’s holdings in CME Group were worth $20,035,000 as of its most recent SEC filing.
A number of other hedge funds have also made changes to their positions in the stock. First Hawaiian Bank acquired a new stake in CME Group during the third quarter worth about $554,000. Raymond James Trust N.A. grew its stake in CME Group by 3.4% during the third quarter. Raymond James Trust N.A. now owns 18,460 shares of the financial services provider’s stock worth $3,142,000 after buying an additional 605 shares in the last quarter. Nisa Investment Advisors LLC grew its stake in CME Group by 13.4% during the third quarter. Nisa Investment Advisors LLC now owns 122,863 shares of the financial services provider’s stock worth $20,912,000 after buying an additional 14,534 shares in the last quarter. Guinness Asset Management Ltd grew its stake in CME Group by 6.1% during the third quarter. Guinness Asset Management Ltd now owns 92,100 shares of the financial services provider’s stock worth $15,676,000 after buying an additional 5,310 shares in the last quarter. Finally, GHP Investment Advisors Inc. grew its stake in CME Group by 6.6% during the third quarter. GHP Investment Advisors Inc. now owns 5,996 shares of the financial services provider’s stock worth $1,021,000 after buying an additional 369 shares in the last quarter. Hedge funds and other institutional investors own 90.59% of the company’s stock.
CME has been the topic of a number of analyst reports. Zacks Investment Research downgraded shares of CME Group from a “buy” rating to a “hold” rating in a research note on Friday, December 7th. Bank of America reiterated a “neutral” rating and set a $191.00 price objective (down from $200.00) on shares of CME Group in a research note on Friday, January 11th. They noted that the move was a valuation call. UBS Group downgraded shares of CME Group from a “buy” rating to a “neutral” rating and increased their price objective for the stock from $185.00 to $204.00 in a research note on Wednesday, November 28th. Berenberg Bank upgraded shares of CME Group from a “hold” rating to a “buy” rating and set a $220.00 price objective on the stock in a research note on Tuesday, November 20th. Finally, BidaskClub downgraded shares of CME Group from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, January 9th. Nine equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. CME Group currently has an average rating of “Hold” and an average price target of $195.21.
In related news, insider Julie Winkler sold 5,847 shares of the firm’s stock in a transaction that occurred on Friday, November 16th. The shares were sold at an average price of $195.01, for a total value of $1,140,223.47. Following the completion of the transaction, the insider now owns 24,255 shares in the company, valued at approximately $4,729,967.55. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CFO John W. Pietrowicz sold 17,960 shares of the firm’s stock in a transaction that occurred on Wednesday, January 2nd. The shares were sold at an average price of $186.92, for a total transaction of $3,357,083.20. Following the completion of the transaction, the chief financial officer now owns 44,780 shares of the company’s stock, valued at approximately $8,370,277.60. The disclosure for this sale can be found here. Insiders sold 52,494 shares of company stock valued at $9,967,852 in the last three months. Company insiders own 0.43% of the company’s stock.
CME stock opened at $180.40 on Thursday. The stock has a market capitalization of $60.81 billion, a PE ratio of 37.82, a P/E/G ratio of 2.18 and a beta of 0.30. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.09 and a quick ratio of 1.09. CME Group Inc has a 12 month low of $153.90 and a 12 month high of $197.08.
The business also recently announced a quarterly dividend, which will be paid on Monday, March 25th. Stockholders of record on Friday, March 8th will be issued a $0.75 dividend. The ex-dividend date of this dividend is Thursday, March 7th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.66%. This is a boost from CME Group’s previous quarterly dividend of $0.70. CME Group’s dividend payout ratio is 58.70%.
TRADEMARK VIOLATION WARNING: “CME Group Inc (CME) Shares Bought by Bp Plc” was first reported by American Banking News and is owned by of American Banking News. If you are reading this piece of content on another website, it was illegally copied and reposted in violation of U.S. & international copyright legislation. The original version of this piece of content can be accessed at https://www.americanbankingnews.com/2019/02/14/cme-group-inc-cme-shares-bought-by-bp-plc.html.
About CME Group
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.